Institutional investors purchased a net $103.1 thousand shares of BSTC during the quarter ended June 2015. This may signal that the smart money is gaining interest in this company as the 55.11% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RK CAPITAL MANAGEMENT LLC Bought 117.2 Thousand shares of Biospecifics Technologies...